DIFIX | HBLYX | DIFIX / HBLYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 18 years | - |
Gain YTD | 6.547 | 8.693 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.09B | 12.5B | 17% |
Annual Yield % from dividends | 3.81 | 3.51 | 108% |
Returns for 1 year | 16.05 | 18.11 | 89% |
Returns for 3 years | -0.09 | -0.08 | 110% |
Returns for 5 years | 12.09 | 17.30 | 70% |
Returns for 10 years | 36.75 | 40.99 | 90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GDXD | 15.70 | 0.74 | +4.95% |
MicroSectors™ Gold Mns 3X Inv Lvrgd ETN | |||
OMFL | 55.28 | -0.05 | -0.09% |
Invesco Russell 1000® Dynamic Mltfct ETF | |||
PPH | 89.53 | -1.16 | -1.28% |
VanEck Pharmaceutical ETF | |||
ISVL | 35.38 | -0.58 | -1.61% |
iShares Intl Dev Sm Cp Val Fctr ETF | |||
HELX | 30.80 | -0.62 | -1.98% |
Franklin Genomic Advancements ETF |